Pharma R&D

Deals/Contracts/Partnerships

• 1

  Innovate Life Sciences Lab and Wipro open genomics testing lab at Dubai Science Park. It will develop affordable technologies that use artificial intelligence and machine learning to analyse genetic data.

  Q1(Jan-Feb-Mar), 2023

• 2

  Persistent is engineering the next generation platform to scale diagnostics and drug discovery business for a leader in immune-driven medicine

  Q2(Apr-May-Jun), 2022

• 3

  Wipro and Pandorum Partner to Accelerate Regenerative Medicine with AI

  Q1(Jan-Feb-Mar), 2022

• 4

  Persistent is aggregating clinical data sources in a Microsoft Azure based data lake for a leading contract research organization.

  Q4(Oct-Nov-Dec), 2021

• 5

  Persistent is developing enterprise integration platform, RPA-based CoE and Azure data lake for clinical trial reporting for a leading biopharmaceutical company.

  Q3(Jul-Aug-Sep), 2021

• 6

  Atos and Huma have announced a 5-year strategic global partnership to shift healthcare and clinical trials from hospital to home. Atos will invest €20 million split across R&D and go-to-market resources, including dedicated consulting and sales personnel. The investment in R&D will fast-track the integration of the Huma platform with other leading clinical platforms, as well as develop a dedicated video module.

  Q2(Apr-May-Jun), 2021

• 7

  TCS has transformed QIAGEN’s GeneGlobe, a genomics-based research platform for biology and biomedical researchers, to improve customer experience.

  Q1(Jan-feb-Mar), 2021

EIIR Provider Solutions/Capabalities

• 1

  Dassault Systèmesis launching Medidata Adjudicate, a clinical endpoint adjudication system, fully integrated with the Medidata Clinical Cloud.

  Q2(Apr-May-Jun), 2021

• 2

  Medidata Launches myMedidata Registries to Transform Awareness, Access, and Retention of Patients in Clinical Trials

  Q2(Apr-May-Jun), 2021

• 3

  Capgemini announces new services that will enable Bio Pharmaceuticals R&D teams to take a novel data driven approach to better understand diseases and patients, identify therapies with higher potential, digitally optimize clinical trials,and accelerate time to market.

  Q4(Oct-Nov-Dec), 2020

• 4

  Takeda accelerates Digital Transformation with Accenture and AWS. The five-year collaboration agreement will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future.

  Q4(Oct-Nov-Dec), 2020

• 5

  Tata Elxsi awarded global services deal from Aesculap aB. Braun Group subsidiary for medical device engineering including product design & engineering, regulatory support and clinical evaluation services.

  Q4(Oct-Nov-Dec), 2020

• 6

  Accenture has made a strategic investment, through Accenture Ventures, in ixlayer, a provider of technology-based solutions for diagnostic testing. The company’s telehealth platform allows players across the healthcare ecosystem to offer convenient and sc

  Q3(Jul-Aug-Sep), 2021

• 7

  FORCE Technology establishes new subsidiary to handle sales and international growth in using AeroCollect technology, which, with simple air samples, provides a picture of the diseases in a herd of animals.

  Q3(Jul-Aug-Sep), 2021

• 8

  EPAM Systems announced that the EPAM Cloud Pipeline, a life sciences solution designed to accelerate drug discovery clinical research, is now released in the Microsoft Azure Marketplace. The EPAM Cloud Pipeline enables scientists to build and run customized scripts and workflows required to support genomics analysis, modeling and simulation, as well as machine learning. The solution is available as a direct integration between cloud and on-premise solutions. It wraps Azure computing and storage resources into a single service, providing an easy and scalable approach required to accomplish a wide range of scientific tasks.

  Q1(Jan-feb-Mar), 2021

• 9

  EPAM Debuts New Cloud-Powered Digital Clinical Trials Platform

  Q4(Oct-Nov-Dec), 2021

• 10

  Expleo acquires Assystem Care for 28 million Euro in move that reinforces its position in life sciences and chemical. Assystem care has 400 people and will bring 39 million Euro in revenue. Assystem Care works with some of the world’s largest healthcare, biopharmaceutical, medical device, prognosis, agribusiness, fine chemicals, and cosmetics companies, to provide compliance, quality, and validation services.

  Q4(Oct-Nov-Dec), 2021

• 11

  Accenture Invests in Good Chemistry Company to Help Drive Quantum Computing Advancements in Materials and Life Sciences

  Q2(Apr-May-Jun), 2022

• 12

  Medidata Launches New Clinical Operations Technologies to Address Critical Issues in Clinical Trial Oversight

  Q3(Jul-Aug-Sep), 2022

• 13

  Globant and Topazium, the biotech startup specialized in integrating the latest advances in artificial intelligence (AI) with traditional medical care, today announced a partnership to deliver AI-powered preclinical, clinical, and diagnostic solutions to

  Q4(Oct-Nov-Dec), 2022

• 14

  Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines

  Q1(Jan-Feb-Mar), 2023

• 15

  Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines

  Q1(Jan-Feb-Mar), 2023

EIIR Buyer GIC/R&D Best Practices/Solutions

Other News

• 1

  Yokogawa Electric Corporation announced the acquisition of Fluence Analytics, Inc., a US-based startup that provides real-time analytics solutions to polymer and biopharmaceutical companies worldwide. provide new insights into material properties that enable customers to optimize and control polymerization processes, leading to improved product quality, greater yields, and less energy consumption and material waste.

  Q1(Jan-Feb-Mar), 2023

• 2

  Novo Nordisk laying off 86 workers as part of lab shutdown in Seattle

  Q1(Jan-Feb-Mar), 2023

• 3

  Pfizer announced cash acquisition of Seagen, a cancer specialist biotech for $43 Billion - largest pharma M&A in 3 years.

  Q1(Jan-Feb-Mar), 2023

• 4

  Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson?s Disease

  Q2(Apr-May-Jun), 2022

• 5

  Unilever and Geno launch $120m venture to scale alternative ingredients. The venture aims to commercialise and scale plant-based alternatives to feedstocks like palm oil, or fossil fuels

  Q2(Apr-May-Jun), 2022

• 6

  Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe

  Q1(Jan-Feb-Mar), 2022

• 7

  Alkermes Announces First Subject Dosed in Phase 1 Study of ALKS 1140 for the Treatment of Neurodegenerative and Neurological Disorders

  Q1(Jan-Feb-Mar), 2022

• 8

  Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine

  Q1(Jan-Feb-Mar), 2022

• 9

  Curia Unveils Comprehensive mRNA Solution

  Q1(Jan-Feb-Mar), 2022

• 10

  Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401

  Q1(Jan-Feb-Mar), 2022

• 11

  Bruker Acquires Prolab Instruments to Augment Multiomics Solutions

  Q1(Jan-Feb-Mar), 2022

• 12

  European Medicines Agency Validates Amicus Therapeutics Marketing Authorization Applications for AT-GAA for the Treatment of Pompe Disease

  Q1(Jan-Feb-Mar), 2022

• 13

  Overland Pharmaceuticals Partners with ArisGlobal to Accelerate Safety Capabilities

  Q1(Jan-Feb-Mar), 2022

• 14

  AbbVie and REGENXBIO Announce Eye Care Collaboration

  Q4(Oct-Nov-Dec), 2021

• 15

  Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campaign to Bring Greater Awareness to Parkinson’s Disease

  Q4(Oct-Nov-Dec), 2021

• 16

  Allergan Aesthetics Enters Into Option to Acquire Cypris Medical

  Q4(Oct-Nov-Dec), 2021

• 17

  Acorda Therapeutics Announces Agreement to Commercialize INBRIJA in Germany for Parkinson's disease patients.

  Q4(Oct-Nov-Dec), 2021

• 18

  New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Ginkgo Bioworks

  Q4(Oct-Nov-Dec), 2021

• 19

  SK Chemicals said it has agreed with Cimplrx, an artificial intelligence-based new drug development company, for joint research and development of new drugs using AI.

  Q4(Oct-Nov-Dec), 2021

• 20

  Curia to Acquire US-Based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics

  Q4(Oct-Nov-Dec), 2021

• 21

  US biotechnology company Amgen is to invest $100 million in the construction of a new vial filling line at its Dublin facility. It is one of the company’s largest outside North America,

  Q4(Oct-Nov-Dec), 2021

• 22

  Baxter to acquire US Medtech provider for smart beds and surgical instruments Hillrom for $12.4B

  Q3(Jul-Aug-Sep), 2021

• 23

  Moderna opening vaccine manufacturing facility in Canada

  Q3(Jul-Aug-Sep), 2021

• 24

  Evonik acquires German biotech company JeNaCell to expand biomaterials portfolio for new medical device markets. Nanostructured biomaterial for wound dressings and dermatology to be integrated into Health Care business

  Q3(Jul-Aug-Sep), 2021

• 25

  World’s first medication created using artificial intelligence that will be clinically tested on humans. The medication, which is meant to treat obsessive-compulsive disorder, took less than a year from conception to trial-ready capsule.

  Q1(Jan-feb-Mar), 2021

• 26

  Medtronic Strengthens Leadership in Navigated, Robotic Spine Surgery with FDA Clearance of Midas Rex Drills and Navigated Disc Prep and Interbodies for U.S. with Mazor Robotic Guidance System

  Q4(Oct-Nov-Dec), 2020

• 27

  Philips buys US remote cardiac care firm BioTelemetry for $2.8 billion

  Q4(Oct-Nov-Dec), 2020

Previous Data

• 1

  Atos establishes Life Sciences Centre of Excellence to support researchers worldwide.

  ,

• 2

  AWS powers Moderna’s Digital Biotechnology Platform to develop new class of vaccines and therapeutics.

  ,

• 3

  BostonGene and NEC Collaborate to analyze cancer patients in clinical trials.

  ,

• 4

  Chugai Pharmaceutical and NTT DATA have conducted a demonstration test of a solution for improving the efficiency of clinical trial-related document preparation using AI technology.

  ,

• 5

  CTI Clinical Trial and Consulting Services, a leading contract research organization, will use Medidata’s Remote Source Review to power remote monitoring and document review for multiple global studies, including several COVID-19 projects.

  ,

• 6

  FORCE Technology is accredited by DANAK for personal protective equipment, and through a partner, it can also offer accredited testing of non-active medical devices including face masks according to the applicable standard DS/EN 14683:2019+AC:2019, which replaces the previous EN 14683:2019

  ,

• 7

  Hitachi has constructed Japan’s first platform for the integrated management of cell and tracing information throughout the value chain, from cell collection, through production and transport, to the administration of regenerative medicine products through collaborative creation with Alfresa, pharmaceutical companies, medical institutions, and others.

  ,

• 8

  Medidata supports Moderna’s COVID-19 vaccine clinical trials with Rave Clinical Cloud Platform.

  ,

• 9

  Merck KGaA opens R&D center at Darmstadt.

  ,

• 10

  Merck to build £1B London R&D hub for its first ex-U.S. early research center.

  ,

• 11

  Spanish National Center for Biotechnology uses Atos supercomputing expertise to find out how Covid-19 virus initiates infection

  ,

• 12

  TietoEVRY and Hyland Healthcare extends their partnership to deliver digital pathology solutions. TietoEVRY’s?Lifecare Pathology LIMS supports a fully digital pathology process, both the laboratory process and the diagnostics, including possible integrations with viewers and image analysis.?

  ,

Jobs

Pharma R&D